Overcoming therapy resistance in pancreatic cancer

Overcoming therapy resistance in pancreatic cancer: New insights ...

Pancreatic adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer deaths by 2030 and this is mostly due to therapy ...

Overcoming therapy resistance in pancreatic cancer: New insights ...

We review hallmarks of therapy resistance in PDAC and current strategies aiming to tackle escape mechanisms and to re-sensitize cancer cells to therapy.

Overcoming Drug Resistance in Pancreatic Cancer - PubMed Central

Drug resistance is a key factor that limits the choice of therapies and significantly decreases the efficacy of any chemotherapy drugs for pancreatic cancer.

Overcoming therapy resistance in pancreatic cancer - DiVA portal

Pancreatic tumors are renowned for their poor response to therapeutic interventions including targeted therapies, chemotherapy and radiotherapy.

Overcoming therapy resistance in pancreatic cancer

Pancreatic tumors are renowned for their poor response to therapeutic interventions including targeted therapies, chemotherapy and radiotherapy. Herein, we ...

Reversing chemotherapy resistance in pancreatic cancer

They found that pancreatic cancer needed two things to become resistant to chemotherapy: a physically stiff extracellular matrix and high ...

Overcoming resistance in pancreatic cancer

In pancreatic cancer cells' struggle to survive, the cells choose alternative routes when their main pathways are blocked by drugs.

Conquering chemoresistance in pancreatic cancer: Exploring novel ...

Combination therapy, supported by nanomedicine, utilizes the synergistic effects of different drugs to target various resistance mechanisms, ...

Communicating science: Brian Lewis discusses overcoming ...

Brian Lewis, PhD, is studying therapeutic resistance in pancreatic cancer cells, hoping to change the grim statistics for patients diagnosed ...

Overcoming therapy resistance in pancreatic cancer - Umeå University

Pancreatic tumors are renowned for their poor response to therapeutic interventions including targeted therapies, chemotherapy and radiotherapy.

Overcoming chemotherapy resistance in pancreatic cancer

Researchers have discovered that pancreatic cancer's resistance to chemotherapy is related to the physical stiffness of the extracellular ...

Overcoming Gemcitabine Resistance in Pancreatic Cancer Using ...

DT2216 has shown promising antitumor activities in BCL-XL–dependent hematologic malignancies when used as single-agent therapy and in multiple solid tumors when ...

The road to overcome pancreatic cancer: Where are we?: Heliyon

Treatment modalities are limited to surgery, chemotherapy, or chemoradiotherapy.Personalized approaches are reserved for specific circumstances. •. Some current ...

Overcoming Cancer Resistance: Strategies and Modalities for ...

Combining immunotherapy with other treatment modalities has shown significant promise in enhancing antitumor responses and overcoming resistance. Immune ...

Novel Holistic Approaches for Overcoming Therapy Resistance in ...

Gastrointestinal (GI) cancers, such as of the colon and pancreas, are highly resistant to both standard and targeted therapeutics. Therapy- ...

Overcoming Therapeutic Resistance in Pancreatic Cancer - YouTube

Brian Lewis, PhD, Professor, Molecular, Cell & Cancer Biology. www.umassmed.edu/mccb.

Pancreatic cancer: New approach to overcoming treatment resistance

A new study led by the Robert Bosch Center for Tumor Diseases in Stuttgart shows how therapy resistance in pancreatic cancer can be prevented or reversed.

Overcoming therapy resistance in pancreatic cancer: New insights ...

Request PDF | On Aug 1, 2024, Margarita Espona-Fiedler and others published Overcoming therapy resistance in pancreatic cancer: New insights ...

Overcoming therapy resistance in pancreatic cancer - OUCI

Ueda, S. et al. The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness Poor Prognosis in Patients With ...

Evaluation of PDT-chemotherapy combinations in 3D tumor models

In combination we found no evidence of any enhancement in efficacy of either PDT or gemcitabine treatment regardless of dose or sequence (PDT ...